NYTimes: A New Covid Breath Test Holds Promise, but Wide Use May Still Be Far Off

212

When it comes to COVID, innovation is all around us, and is what provides glimmers of hope to finally end the pandemic that has been going on now for two years. A Texas-based biotech company has developed a breath test intended to detect the presence of COVID-19. Despite recording high accuracy, the test itself is difficult to deliver, with trained professionals needed to administer it, and a testing device the size of a carryon suitcase. This kind of device can provide results in about three minutes, which is much hastier than the current few hours minimum it takes to return accurate PCR results. Further than COVID, this test provides promise for breath-based testing that could be used for diseases such as lung cancer, which also change the compounds expelled in our breath. The precedent set by this device is very exciting and promising for the future. To read the full article, click here. To read more about COVID-19, click here.

Comments are closed.

Skip to toolbar